Filters

Tim Spelman, Michael Ng, Lauren Thomas, Kevin Bax, Nathan Lawrentschuk, James Symons, Henry Woo, Lih-Ming Wong, Tom Sutherland, Elisa Perry, Vy Tran, Niall Corcoran, Daniel Lenaghan, Nicholas Buchan, Ahmed Saeed Goolam, Venu Chalasani, Justin Hegarty, Alexandar Christov, Hadia Khanani, Su-Faye Lee, Kim Taubman, Lisa Tarlinton

European urology oncology 2024;7(5):1015-1023

Free Full Text

Abstract

Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.

Kento Imajo, Louise Tetlow, Andrea Dennis, Elizabeth Shumbayawonda, Sofia Mouchti, Timothy J Kendall, Eve Fryer, Shogi Yamanaka, Yasushi Honda, Takaomi Kessoku, Yuji Ogawa, Masato Yoneda, Satoru Saito, Catherine Kelly, Matt D Kelly, Rajarshi Banerjee, Atsushi Nakajima

World journal of gastroenterology 2021;27(7):609-623

Free Full Text

Abstract

F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 1. Improved Risk Stratification for MRI-Guided Transrectal Prostate Biopsies.

Matthew S Davenport, Jeffrey S Montgomery, Lakshmi Priya Kunju, Javed Siddiqui, Prasad R Shankar, Thekkelnaycke Rajendiran, Xia Shao, Eunjee Lee, Brian Denton, Christine Barnett, Morand Piert

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020;61(3):337-343

Free Full Text

Abstract

Fluorine-18 Prostate-Specific Membrane Antigen-1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer.

Christopher Fung, Adam Kinnaird, Frank Wuest, Wendy Tu, Evangelos Michelakis, Yuan Gao, Nikhile Mookerji, Tyler Pfanner, Amaris Hui, Guocheng Huang, Patrick Albers, Rohan Mittal, Stacey Broomfield, Lucas Dean, Blair St Martin, Niels-Erik Jacobsen, Howard Evans, Ryan Hung, Jonathan Abele, Peter Dromparis, Joema Felipe Lima, Tarek Bismar, Gopinath Sutendra, Benjamin A Adam, Alexander Tamm

JAMA oncology 2024;10(8):1097-1103

Free Full Text

Abstract

Radical Prostatectomy Without Prior Biopsy in Selected Patients Evaluated by F-Labeled Prostate-Specific Membrane Antigen-Ligand Positron Emission Tomography/Computed Tomography and Multiparameter Magnetic Resonance Imaging: A Single-Center, Prospective, Single-Arm Trial.

Jiajin Liu, Weijun Fu, Baojun Wang, Yu Gao, Xu Zhang, Xin Ma, Wei Chen, Shaoxi Niu, Xiaohui Ding, Baichuan Liu, Liyan Ao, Haiyi Wang, Baixuan Xu, Alberto Olivero, Jiangping Gao, Hongzhao Li, Yachao Liu

The Journal of urology 2024;212(2):280-289

Full Text

Abstract

The accuracy of fluorine 18-labelled prostate-specific membrane antigen PET/CT and MRI for diagnosis of prostate cancer in PSA grey zone.

Hongjun Xie, Hua Liang, Jin Shang, Lu Bai, Xiaoyi Duan, Liang Luo, Xinyi Wang, Yang Li, Yan Li, Ruiyan Wang, Ruxi Chang, Weixuan Dong

British journal of cancer 2025;132(3):253-258

Free Full Text

Abstract

A structurally optimized FXR agonist, MET409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis.

Stephen A Harrison, Mustafa R Bashir, Kyoung-Jin Lee, Jennifer Shim-Lopez, Jonathan Lee, Brandee Wagner, Nicholas D Smith, Hubert C Chen, Eric J Lawitz

Journal of hepatology 2022;75(1):25-33

Full Text

Abstract

Results: 1 – 13 / 13

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Multiparametric Magnetic Resonance Imaging""[mesh_terms]

Multiparametric whole-body MRI of patients with neurofibromatosis type I: spectrum of imaging findings.

Multiparametric MR Urography: State of the Art.

Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease.

A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk.

In vivo assessment of pediatric kidney function using multi-parametric and multi-nuclear functional magnetic resonance imaging: challenges, perspectives, and clinical applications.

Exploring the role of multimodal [F]F-PSMA-1007 PET/CT and multiparametric MRI data in predicting ISUP grading of primary prostate cancer.

Fluorine-18-labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL).

Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.

F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 1. Improved Risk Stratification for MRI-Guided Transrectal Prostate Biopsies.

Fluorine-18 Prostate-Specific Membrane Antigen-1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer.

Radical Prostatectomy Without Prior Biopsy in Selected Patients Evaluated by F-Labeled Prostate-Specific Membrane Antigen-Ligand Positron Emission Tomography/Computed Tomography and Multiparameter Magnetic Resonance Imaging: A Single-Center, Prospective, Single-Arm Trial.

The accuracy of fluorine 18-labelled prostate-specific membrane antigen PET/CT and MRI for diagnosis of prostate cancer in PSA grey zone.

A structurally optimized FXR agonist, MET409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis.

Results for

""Multiparametric Magnetic Resonance Imaging""[mesh_terms]